Aspiriant LLC’s BlackRock Enhanced Equity Dividend Trust BDJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-12,900
Closed -$128K – 277
2022
Q1
$128K Buy
+12,900
New +$126K 0.01% 270

Other funds holding BDJ

Aspiriant LLC's BDJ Position: Q2 2022 in Review

Aspiriant LLC sold out of BlackRock Enhanced Equity Dividend Trust (BDJ) in Q2 2022, closing a stake of 12,900 shares — an estimated $128K sold.

Aspiriant LLC first reported a position in BDJ in Q1 2022 and held it in 1 quarter. The position peaked at $128K in Q1 2022. 186 funds tracked by Wall St. Rank hold BDJ as of Q2 2022.

  • Aspiriant LLC reported no remaining BlackRock Enhanced Equity Dividend Trust position as of Q2 2022 after selling out during the quarter.
  • Aspiriant LLC sold 12,900 BlackRock Enhanced Equity Dividend Trust shares in Q2 2022, an estimated $128K.
  • Aspiriant LLC first reported a position in BlackRock Enhanced Equity Dividend Trust in Q1 2022 and held it in 1 quarter.
  • Aspiriant LLC's BlackRock Enhanced Equity Dividend Trust position peaked at $128K in Q1 2022.
  • 186 funds tracked by Wall St. Rank held BlackRock Enhanced Equity Dividend Trust as of Q2 2022.

Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.